User profiles for "author:Katie Jeffery"

Katie Jeffery

Oxford University Hospital NHS Foundation Trust
Verified email at burcot.net
Cited by 30348

Candida auris: a review of the literature

A Jeffery-Smith, SK Taori, S Schelenz… - Clinical microbiology …, 2018 - Am Soc Microbiol
The emerging pathogen Candida auris has been associated with nosocomial outbreaks on
five continents. Genetic analysis indicates the simultaneous emergence of separate clades …

[HTML][HTML] Do infectious diseases drive MHC diversity?

KJM Jeffery, CRM Bangham - Microbes and infection, 2000 - Elsevier
The primary function of the major histocompatibility complex (MHC) is to allow the immune
system to identify infectious pathogens and eliminate them. Infectious diseases are now …

Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report

P Horby, WS Lim, J Emberson, M Mafham, J Bell… - MedRxiv, 2020 - medrxiv.org
ABSTRACT Background Coronavirus disease 2019 (COVID-19) is associated with diffuse
lung damage. Corticosteroids may modulate immune-mediated lung injury and reducing …

[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses

W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B. 1.1.
529 was announced, containing far more mutations in Spike (S) than previously reported …

[PDF][PDF] Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum

A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc… - Cell, 2022 - cell.com
The Omicron lineage of SARS-CoV-2, which was first described in November 2021, spread
rapidly to become globally dominant and has split into a number of sublineages. BA. 1 …

[HTML][HTML] Antibody status and incidence of SARS-CoV-2 infection in health care workers

SF Lumley, D O'Donnell, NE Stoesser… - … England Journal of …, 2021 - Mass Medical Soc
Background The relationship between the presence of antibodies to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection …

[PDF][PDF] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

RP Payne, S Longet, JA Austin, DT Skelly… - Cell, 2021 - cell.com
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At …

Development of novel treatments for hepatitis C

DP Webster, P Klenerman, J Collier… - The Lancet infectious …, 2009 - thelancet.com
Hepatitis C virus (HCV) infection is a major and growing global health problem, affecting
about 170 million people worldwide, and is a leading cause of liver cirrhosis and …

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

KJM Jeffery, K Usuku, SE Hall… - Proceedings of the …, 1999 - National Acad Sciences
The risk of disease associated with persistent virus infections such as HIV-I, hepatitis B and
C, and human T-lymphotropic virus-I (HTLV-I) is strongly determined by the virus load …

Multilocus Sequence Typing of Clostridium difficile

D Griffiths, W Fawley, M Kachrimanidou… - Journal of clinical …, 2010 - Am Soc Microbiol
ABSTRACT A robust high-throughput multilocus sequence typing (MLST) scheme for
Clostridium difficile was developed and validated using a diverse collection of 50 reference …